Current Perspective on the Treatment of the Novel Coronavirus Infection COVID-19

COVID-19, caused by the novel coronavirus SARS-CoV-2, has emerged as one of the most serious global health challenges in recent decades. The treatment of this condition has proven to be a complex task due to the lack of specific therapies and a clear understanding of its pathogenesis. A review of the literature on the treatment of COVID-19 at various stages has indicated that the prescription of many medications was often spontaneous and lacked an evidence-based foundation, relying instead on presumed effects. This approach was largely driven by the necessity for rapid response from the medical community. However, the safety of many of these medications remains inadequately studied. Furthermore, when employing various groups of medications — ranging from antiviral agents to corticosteroids — it is crucial to consider potential interactions among different drugs to minimize risks for patients. This article presents the results of a retrospective study on the efficacy and side effects of the main groups of medications used in the treatment of COVID-19.

Authors

Institutions

Publication Details

Journal
Antibiot Khimioter = Antibiotics and Chemotherapy
Published
2025-06-09
DOI
https://doi.org/10.37489/0235-2990-2025-70-1-2-88-99
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Current Perspective on the Treatment of the Novel Coronavirus Infection COVID-19

З. А. Камбачокова, И. Х. Борукаева, A. A. Kardanov, A. A. Kambachokova et al.
Antibiot Khimioter = Antibiotics and Chemotherapy
COVID-19 Clinical Research Studies
article

Current Perspective on the Treatment of the Novel Coronavirus Infection COVID-19

З. А. Камбачокова, И. Х. Борукаева, A. A. Kardanov, A. A. Kambachokova, З. Х. Абазова, Динара Артуровна Шогенова, Sh. M. Baskariev, E. B. Mezhikhova, M. S. Djabrailova, Z. I. Сhanieva, Kh. Kh. Akhmatov, M. A. Abdurakhmanov
article en

Abstract

COVID-19, caused by the novel coronavirus SARS-CoV-2, has emerged as one of the most serious global health challenges in recent decades. The treatment of this condition has proven to be a complex task due to the lack of specific therapies and a clear understanding of its pathogenesis. A review of the literature on the treatment of COVID-19 at various stages has indicated that the prescription of many medications was often spontaneous and lacked an evidence-based foundation, relying instead on presumed effects. This approach was largely driven by the necessity for rapid response from the medical community. However, the safety of many of these medications remains inadequately studied. Furthermore, when employing various groups of medications — ranging from antiviral agents to corticosteroids — it is crucial to consider potential interactions among different drugs to minimize risks for patients. This article presents the results of a retrospective study on the efficacy and side effects of the main groups of medications used in the treatment of COVID-19.

Antibiot Khimioter = Antibiotics and ChemotherapyVol. 70(1-2)
Kabardino-Balkarian State University (RU)
Openalex Percentile: Top 83%
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.